- Filed
- Apr 27, 2023 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2023 · Mar 31, 2023 | 41.67M sh |
| Shares Diluted | Q1 2023 · Mar 31, 2022 | 29.7M sh |
| Shares Outstanding | Q1 2023 · Mar 31, 2023 | 41.69M sh |
| Operating Cash Flow | Q1 2023 · Mar 31, 2023 | −$51.6M |
| Operating Cash Flow | Q1 2023 · Mar 31, 2022 | −$20.12M |
| Long Term Debt | Q1 2023 · Mar 31, 2023 | $223.35M |
| Long Term Debt | Q1 2023 · Dec 31, 2022 | $223.1M |
| Short Term Debt | Q1 2023 · Mar 31, 2023 | $109.69M |
| Short Term Debt | Q1 2023 · Dec 31, 2022 | $109.57M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2023 | $61.4M |
| Cash And Equivalents | Q1 2023 · Dec 31, 2022 | $50.52M |
| Cash And Equivalents | Q1 2023 · Mar 31, 2022 | $48.32M |
| Stockholders Equity | Q1 2023 · Mar 31, 2023 | $67.19M |
| Stockholders Equity | Q1 2023 · Dec 31, 2022 | $93.08M |
| Stockholders Equity | Q1 2023 · Mar 31, 2022 | −$371.76M |
| Stockholders Equity | Q1 2023 · Dec 31, 2021 | −$183.96M |
| Current Liabilities | Q1 2023 · Mar 31, 2023 | $207.12M |
| Current Liabilities | Q1 2023 · Dec 31, 2022 | $230.08M |
| Total Liabilities | Q1 2023 · Mar 31, 2023 | $436.9M |
| Total Liabilities | Q1 2023 · Dec 31, 2022 | $460.63M |
| Current Assets | Q1 2023 · Mar 31, 2023 | $490.46M |
| Current Assets | Q1 2023 · Dec 31, 2022 | $540.13M |
| Total Assets | Q1 2023 · Mar 31, 2023 | $504.09M |
| Total Assets | Q1 2023 · Dec 31, 2022 | $553.71M |
| Eps Diluted | Q1 2023 · Mar 31, 2023 | −$0.77 |
| Eps Diluted | Q1 2023 · Mar 31, 2022 | −$0.58 |
| Eps Basic | Q1 2023 · Mar 31, 2023 | −$0.77 |
| Eps Basic | Q1 2023 · Mar 31, 2022 | −$0.58 |
| Sga Expense | Q1 2023 · Mar 31, 2023 | $57.66M |
| Sga Expense restated | Q1 2023 · Mar 31, 2022 | $37.77M |
| Rd Expense | Q1 2023 · Mar 31, 2023 | $41.71M |
| Rd Expense restated | Q1 2023 · Mar 31, 2022 | $47.58M |
| Net Income | Q1 2023 · Mar 31, 2023 | −$32.14M |
| Net Income | Q1 2023 · Mar 31, 2022 | −$17.28M |
| Operating Income | Q1 2023 · Mar 31, 2023 | −$31.63M |
| Operating Income restated | Q1 2023 · Mar 31, 2022 | −$26.43M |
| Cost Of Revenue | Q1 2023 · Mar 31, 2023 | $222K |
| Cost Of Revenue restated | Q1 2023 · Mar 31, 2022 | $223K |
| Revenue | Q1 2023 · Mar 31, 2023 | $67.96M |
| Revenue restated | Q1 2023 · Mar 31, 2022 | $59.15M |
| Capex | Q1 2023 · Mar 31, 2022 | $7K |